These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29313817)

  • 1. Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.
    Kok MM; von Birgelen C; Sattar N; Zocca P; Löwik MM; Danse PW; Schotborgh CE; Scholte M; Hartmann M; Kant GD; Doelman C; Tjon Joe Gin M; Stoel MG; van Houwelingen G; Linssen GCM; IJzerman MJ; Doggen CJM; van der Heijden LC
    EuroIntervention; 2018 Oct; 14(9):e1049-e1056. PubMed ID: 29313817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary intervention.
    Wang H; Song Y; Tang X; Xu J; Jiang P; Jiang L; Gao Z; Chen J; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J; Gao L
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):644-651. PubMed ID: 32143897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
    Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
    Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
    von Birgelen C; Kok MM; Sattar N; Zocca P; Doelman C; Kant GD; Löwik MM; van der Heijden LC; Sen H; van Houwelingen KG; Stoel MG; Louwerenburg JHW; Hartmann M; de Man FHAF; Linssen GCM; Doggen CJM; Tandjung K
    JACC Cardiovasc Interv; 2018 Mar; 11(5):448-459. PubMed ID: 29454724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: a prospective cohort study in Asia.
    Cui K; Yin D; Song W; Wang H; Zhu C; Feng L; Li J; Jia L; Lu Y; Zhang R; Shi B; Song Y; Fu R; Dou K
    Eur J Prev Cardiol; 2023 Oct; 30(14):1418-1426. PubMed ID: 36987575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
    Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
    Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population.
    Nakagami T; Tanaka Y; Oya J; Kurita M; Isago C; Hasegawa Y; Ito A; Hirota N; Tsuzura R; Uchigata Y
    Prim Care Diabetes; 2016 Dec; 10(6):407-414. PubMed ID: 27515716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study.
    Song C; Yuan S; Cui K; Cai Z; Zhang R; He J; Qiao Z; Bian X; Wu S; Wang H; Shi B; Lin Z; Fu R; Wang C; Liu Q; Jia L; Dong Q; Dou K
    Cardiovasc Diabetol; 2023 Mar; 22(1):68. PubMed ID: 36966299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
    Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
    Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.
    Sabatine MS; Leiter LA; Wiviott SD; Giugliano RP; Deedwania P; De Ferrari GM; Murphy SA; Kuder JF; Gouni-Berthold I; Lewis BS; Handelsman Y; Pineda AL; Honarpour N; Keech AC; Sever PS; Pedersen TR
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):941-950. PubMed ID: 28927706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent.
    Chun KH; Im E; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    J Korean Med Sci; 2017 Oct; 32(10):1603-1609. PubMed ID: 28875603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Choi WG; Rha SW; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Kim EJ; Park CG; Seo HS
    Yonsei Med J; 2018 Jun; 59(4):489-494. PubMed ID: 29749131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.
    Balakrishnan R; Berger JS; Tully L; Vani A; Shah B; Burdowski J; Fisher E; Schwartzbard A; Sedlis S; Weintraub H; Underberg JA; Danoff A; Slater JA; Gianos E
    Diabetes Metab Res Rev; 2015 Sep; 31(6):603-9. PubMed ID: 25728823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients.
    Chan DML; Murphy M
    J R Nav Med Serv; 2017; 103(1):39-43. PubMed ID: 30088739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study.
    Wu S; Shi Y; Pan Y; Li J; Jia Q; Zhang N; Zhao X; Liu G; Wang Y; Wang Y; Wang C
    BMC Neurol; 2014 Sep; 14():177. PubMed ID: 25209629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Punthanitisarn S
    J Clin Pharm Ther; 2016 Apr; 41(2):180-8. PubMed ID: 27009750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus.
    Yang Y; Hyun J; Lee J; Kim JH; Lee JB; Kang DY; Lee PH; Ahn JM; Park DW; Park SJ;
    JACC Asia; 2021 Sep; 1(2):173-184. PubMed ID: 36338165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Prediabetes Compared with Normoglycaemia and Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Ahsan MJ; Latif A; Ahmad S; Willman C; Lateef N; Shabbir MA; Ahsan MZ; Yousaf A; Riasat M; Ghali M; Siller-Matula J; Gwon Y; Mamas MA; Brilakis ES; Abbott JD; Bhatt DL; Velagapudi P
    Heart Int; 2023; 17(1):45-53. PubMed ID: 37456347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.